Caxton Associates (New York)’s Ardelyx ARDX Stock Holding History
Bought
Maintained
Sold
Other funds holding ARDX
EAM
RCMNY
Caxton Associates (New York)'s ARDX Position: Q3 2024 in Review
Caxton Associates (New York) sold out of Ardelyx (ARDX) in Q3 2024, closing a stake of 34,971 shares — an estimated $259K sold.
Caxton Associates (New York) first reported a position in ARDX in Q4 2019 and held it in 3 quarters. The position peaked at $287K in Q4 2022. 203 funds tracked by Wall St. Rank hold ARDX as of Q3 2024.
- Caxton Associates (New York) reported no remaining Ardelyx position as of Q3 2024 after selling out during the quarter.
- Caxton Associates (New York) sold 34,971 Ardelyx shares in Q3 2024, an estimated $259K.
- Caxton Associates (New York) first reported a position in Ardelyx in Q4 2019 and held it in 3 quarters.
- Caxton Associates (New York)'s Ardelyx position peaked at $287K in Q4 2022.
- 203 funds tracked by Wall St. Rank held Ardelyx as of Q3 2024.
Based on Caxton Associates (New York)'s 13F filing for Q3 2024, filed 14 Nov 2024.